Kawasaki Disease in Children Older Than 10 Years: A Clinical Experience From Northwest India

Ankur Kumar Jindal1, Rakesh Kumar Pilania1, Sandesh Guleria1

  • 1Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

Insights

Diagnosing Kawasaki disease (KD) in older children is often delayed, increasing their risk for coronary artery abnormalities (CAAs). This study highlights the challenges and outcomes in patients aged 10 and above.

Area of Science:

  • Pediatrics
  • Cardiology
  • Rheumatology

Background:

  • Kawasaki disease (KD) primarily affects children under 5.
  • Delayed diagnosis in older children (≥10 years) elevates the risk of coronary artery abnormalities (CAAs).
  • Limited research exists on KD presentation and outcomes in older pediatric populations.

Purpose of the Study:

  • To investigate the characteristics of Kawasaki disease in patients aged 10 years and older.
  • To assess the diagnostic delay and associated risks, particularly CAAs, in this understudied group.

Main Methods:

  • Retrospective review of medical records for patients diagnosed with KD aged ≥10 years.
  • Data collected from January 1994 to June 2019.
  • Analysis of clinical presentation, diagnostic intervals, treatment, and outcomes, including CAAs.

Main Results:

  • 46 patients (5.3%) aged ≥10 years were diagnosed with KD, with a median age of 11 years.
  • Median delay between fever onset and diagnosis was 12 days.
  • Coronary artery abnormalities (CAAs) occurred in 13.04% of older patients; 17.4% presented with hypotensive shock.

Conclusions:

  • Delayed diagnosis is common in older children with Kawasaki disease.
  • Patients aged 10 and above diagnosed with KD face a heightened risk of developing CAAs.
  • Early recognition and treatment are crucial to mitigate severe cardiovascular complications.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
367
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
299
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
348
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
195